Increase/Decrease in Cash: The total change in cash for the company over the given period.
Sernova Biotherapeutics Inc. (SEOVF) had Increase/Decrease in Cash of $-4.10M for the most recently reported fiscal quarter, ending 2025-10-31.
| Income Statement Financials | |
-- |
|
$-1.46M |
|
-- |
|
-- |
|
$1.63M |
|
$-1.63M |
|
$0.13M |
|
$-1.50M |
|
$-1.50M |
|
$-1.45M |
|
$-1.45M |
|
$-1.46M |
|
$-1.45M |
|
$-1.63M |
|
$-1.59M |
|
328.29M |
|
328.29M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.37M |
|
$0.01M |
|
$0.17M |
|
$0.55M |
|
$17.70M |
|
$0.74M |
|
$0.74M |
|
$18.45M |
|
$-17.90M |
|
$-17.90M |
|
$-17.90M |
|
332.86M |
|
| Cash Flow Statement Financials | |
$-7.79M |
|
$0.02M |
|
$3.67M |
|
$4.29M |
|
$0.19M |
|
|
Increase/Decrease in Cash |
$-4.10M |
$1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.04 |
|
-0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.08% |
|
8.08% |
|
-265.20% |
|
8.43% |
|
$-0.05 |
|
$-0.02 |
|
$-0.02 |
|